A phase Ib study of abemaciclib with therapies for metastatic breast cancer.

被引：9
|
作者：
Tolaney, Sara M.
Beeram, Muralidhar
Beck, J. Thaddeus
Conlin, Alison Katherine
Dees, Elizabeth Claire
Dickler, Maura N.
Helsten, Teresa L.
Conkling, Paul R.
Edenfield, William Jeffery
Richards, Donald A.
Turner, P. Kellie
Cai, Na
Chan, Edward Michael
Pant, Shubham
Becerra, Carlos
Kalinsky, Kevin
Puhalla, Shannon
Rexer, Brent Neil
Burris, Howard A.
Goetz, Matthew P.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] START Ctr Canc Care, San Antonio, TX USA
[3] Highlands Oncol Grp, Fayetteville, AR USA
[4] Providence Canc Ctr, Oncol & Hematol Care Clin, Portland, OR USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[7] Univ Calif San Diego, La Jolla, CA USA
[8] Virginia Oncol Associates, Norfolk, VA USA
[9] ITOR Greenville Hosp Syst, Clin Res Unit, Greenville, SC USA
[10] Texas Oncol Tyler, Tyler, TX USA
[11] Eli Lilly & Co, Indianapolis, IN 46285 USA
[12] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
[13] Texas Oncol Baylor Sammons Canc Ctr, Dallas, TX USA
[14] Columbia Univ, Med Ctr, New York, NY USA
[15] Univ Pittsburgh, Med Ctr, Womens Canc Program, Magee Womens Hosp UMPC, Pittsburgh, PA USA
[16] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[17] Sarah Cannon Res Inst SCRI, Nashville, TN USA
[18] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.522
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
522
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of ixabepilone and vorinostat in metastatic breast cancer.
    Luu, Thehang H.
    Blanchard, Suzette
    Beumer, Jan Hendrik
    Anyang, Bean N.
    Somlo, George
    Mortimer, Joanne E.
    Hurria, Arti
    Yang, Lixin
    Yen, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] A phase I trial of palbociclib and paclitaxel in metastatic breast cancer.
    Clark, Amy Sanders
    O'Dwyer, Peter J.
    Heitjan, Daniel
    Lal, Priti
    Feldman, Michael D.
    Gallagher, Maryann
    Redlinger, Colleen
    Colameco, Christopher
    Lewis, David
    Zafman, Kelly
    Langer, Melissa
    Rosen, Mark Alan
    Gogineni, Keerthi
    Bradbury, Angela R.
    Domchek, Susan M.
    Fox, Kevin R.
    DeMichele, Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Fulvestrant in metastatic breast cancer.
    Steger, GG
    Bartsch, R
    Wenzel, C
    Pluschnig, U
    Hussian, D
    Mader, RM
    Zielinski, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S104 - S104
  • [34] Update on metastatic breast cancer.
    Perez E.A.
    Current Oncology Reports, 1999, 1 (1) : 11 - 15
  • [35] A phase 2 study of napabucasin with weekly paclitaxel in previously treated metastatic breast cancer.
    Edenfield, William Jeffery
    Becerra, Carlos
    Langleben, Adrian
    Spira, Alexander I.
    Braiteh, Fadi S.
    Kossler, Kimiko
    Gao, Yuan
    Li, Youzhi
    Hitron, Matthew
    Li, Chiang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Retrospective study on survival of patients with metastatic breast cancer.
    Racine-Rainville, Michele
    Roy, Josee-Anne
    Lesperance, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] A Phase Ib Trial of Erlotinib, an EGFR Inhibitor, and Everolimus (RAD001), an mTOR Inhibitor, in Patients with Metastatic Breast Cancer.
    Mayer, I. A.
    Means-Powell, J.
    Shyr, Y.
    Arteaga, C. L.
    CANCER RESEARCH, 2009, 69 (24) : 677S - 677S
  • [38] Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results
    Kagawa, Y.
    Satake, H.
    Kato, T.
    Oba, K.
    Yasui, H.
    Nakamura, M.
    Watanabe, T.
    Hirata, K.
    Muro, K.
    Komatsu, Y.
    Yoshino, T.
    Yamazaki, K.
    Mishima, H.
    Kotaka, M.
    Tsuji, A.
    Kakeji, Y.
    Oki, E.
    Nagata, N.
    Junichi, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] A phase 2 study of abemaciclib monotherapy for patients with retinoblastoma-positive (Rb plus ), triplenegative metastatic breast cancer
    Goel, Shom
    Jovanovic, Bojana
    Chu, Xiangying
    Hughes, Melissa
    Mohammed-Abreu, Ayesha
    Kasparian, Julie
    Erick, Timothy
    DiLullo, Molly
    Wrabel, Eileen
    Jeselsohn, Rinath
    Tayob, Nabihah
    Schnitt, Stuart
    Lin, Nancy
    Tolaney, Sara
    CANCER RESEARCH, 2024, 84 (09)
  • [40] Phase Ib/II study of LEE011, everolimus, and exemestane in postmenopausal women with ER+/HER2-metastatic breast cancer.
    Bardia, Aditya
    Modi, Shanu
    Gregor, Mariana Chavez-Mac
    Kittaneh, Muaiad
    Marino, Alyssa J.
    Matano, Alessandro
    Bhansali, Suraj
    Hewes, Becker
    Cortes, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345